Trial of 6% HES130/0.4

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2009
The study shall evaluate the efficacy and safety of two different hydroxyethyl starch solutions (artificial colloids 6% HES130/0.4 and 6% HES70/0.5, Salinhes®) for intra-operative therapy of hypovolemia and maintenance of circulating blood volume in patients undergoing orthopedic surgery. The primary efficacy endpoint will be the required volume of colloid solution infused from start until end of surgery. It is the aim of the clinical trial to demonstrate that comparable volumes of colloid solution are used between treatment groups.
Epistemonikos ID: b9b3fffc50588a33830856f885b063685e057dbc
First added on: May 05, 2024